載入...
Management of patients with hereditary angioedema in Germany: comparison with other countries in the Icatibant Outcome Survey
BACKGROUND: The Icatibant Outcome Survey (IOS; NCT01034969) is a Shire‐sponsored, international, observational study monitoring the safety and effectiveness of icatibant, a bradykinin B2 receptor antagonist approved for the acute treatment of adults with hereditary angioedema with C1 inhibitor defic...
Na minha lista:
| 發表在: | J Eur Acad Dermatol Venereol |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6587717/ https://ncbi.nlm.nih.gov/pubmed/30176179 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdv.15232 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|